granzyme M Antibodies

Santa Cruz Biotechnology provides a broad selection of granzyme M monoclonal antibodies for investigating the role of this serine protease in immune responses. granzyme M Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Granzyme M is a key player in the immune system, primarily involved in the induction of apoptosis in target cells during cytotoxic responses. It is secreted by cytotoxic T lymphocytes and natural killer cells, contributing to the elimination of infected or malignant cells. Understanding granzyme M function is crucial for elucidating mechanisms of immune regulation and potential therapeutic interventions in cancer and autoimmune diseases. Granzyme M research has revealed significant insights into cellular immunity and cytotoxic responses. Recent studies have highlighted the importance of granzyme M in various physiological and pathological conditions. Ongoing research continues to uncover new aspects of granzyme M biology and its potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of immune system regulation and disease mechanisms.